This is the authors' abstract. We don't add key points for this paper.
Fast-acting peptide-based antimicrobials that target bacterial membranes are herein addressed and promise a breakthrough in chronic wound care. Two peptide hybrids (3.1-PP4 and PP4-3.1), engineered by us, resulted from linking PP4 (a non-antimicrobial anti-aging peptide used in cosmetics) to the antimicrobial peptide 3.1. In contrast, the replacement of the latter with an antimicrobial ionic liquid afforded an ionic liquid-peptide conjugate C16-Im-PP4. Herein, we demonstrate their rapid bactericidal action by targeting bacterial membranes via a combination of biophysical assays and microscopy using liposome models of bacterial membranes and live bacteria. Interestingly, the peptide hybrids share a similar membrane-disruptive mechanism against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli. In turn, the ionic liquid-peptide conjugate C16-Im-PP4 displayed bacterial-type-dependent behavior. These findings underscore the potential of peptide-based agents to address chronic wounds, which remain vulnerable to infection due to prolonged inflammation and rising antibiotic resistance that is increasingly regarded as a “silent pandemic”.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: